PL1839120T3 - Wektory oparte na przeciwciałach anty-IL-12, komórki gospodarza oraz metody wytwarzania i zastosowania - Google Patents
Wektory oparte na przeciwciałach anty-IL-12, komórki gospodarza oraz metody wytwarzania i zastosowaniaInfo
- Publication number
- PL1839120T3 PL1839120T3 PL05855447T PL05855447T PL1839120T3 PL 1839120 T3 PL1839120 T3 PL 1839120T3 PL 05855447 T PL05855447 T PL 05855447T PL 05855447 T PL05855447 T PL 05855447T PL 1839120 T3 PL1839120 T3 PL 1839120T3
- Authority
- PL
- Poland
- Prior art keywords
- production
- methods
- host cells
- based vectors
- antibody based
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/24—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
- C07K16/244—Interleukins [IL]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
- C12N15/1034—Isolating an individual clone by screening libraries
- C12N15/1086—Preparation or screening of expression libraries, e.g. reporter assays
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Medicinal Chemistry (AREA)
- Immunology (AREA)
- Plant Pathology (AREA)
- Microbiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Physics & Mathematics (AREA)
- Crystallography & Structural Chemistry (AREA)
- Bioinformatics & Computational Biology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US63793604P | 2004-12-21 | 2004-12-21 | |
| PCT/US2005/046885 WO2006071804A2 (en) | 2004-12-21 | 2005-12-21 | Anti-il-12 antibody based vectors, host cells, and methods of production and uses |
| EP05855447.8A EP1839120B1 (en) | 2004-12-21 | 2005-12-21 | Anti-il-12 antibody based vectors, host cells, and methods of production and uses |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL1839120T3 true PL1839120T3 (pl) | 2014-04-30 |
Family
ID=36615455
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL05855447T PL1839120T3 (pl) | 2004-12-21 | 2005-12-21 | Wektory oparte na przeciwciałach anty-IL-12, komórki gospodarza oraz metody wytwarzania i zastosowania |
Country Status (8)
| Country | Link |
|---|---|
| US (2) | US7736650B2 (pl) |
| EP (1) | EP1839120B1 (pl) |
| DK (1) | DK1839120T3 (pl) |
| ES (1) | ES2440777T3 (pl) |
| PL (1) | PL1839120T3 (pl) |
| PT (1) | PT1839120E (pl) |
| SI (1) | SI1839120T1 (pl) |
| WO (1) | WO2006071804A2 (pl) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PL1839120T3 (pl) * | 2004-12-21 | 2014-04-30 | Janssen Biotech Inc | Wektory oparte na przeciwciałach anty-IL-12, komórki gospodarza oraz metody wytwarzania i zastosowania |
| EP2214708A4 (en) | 2007-10-26 | 2011-01-12 | Centocor Ortho Biotech Inc | VECTORS, HOST CELLS, METHODS OF PRODUCTION AND USES |
| WO2014102100A1 (en) * | 2012-12-31 | 2014-07-03 | Boehringer Ingelheim International Gmbh | Heterologous intron within an immunoglobulin domain |
| EP2938726B1 (en) * | 2012-12-31 | 2017-09-27 | Boehringer Ingelheim International GmbH | Heterologous intron within a signal peptide |
| WO2014102104A1 (en) | 2012-12-31 | 2014-07-03 | Boehringer Ingelheim International Gmbh | Artificial introns |
| WO2014102101A1 (en) * | 2012-12-31 | 2014-07-03 | Boehringer Ingelheim International Gmbh | Novel intron sequences |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4873191A (en) | 1981-06-12 | 1989-10-10 | Ohio University | Genetic transformation of zygotes |
| US4870009A (en) | 1982-11-22 | 1989-09-26 | The Salk Institute For Biological Studies | Method of obtaining gene product through the generation of transgenic animals |
| US4736866B1 (en) | 1984-06-22 | 1988-04-12 | Transgenic non-human mammals | |
| JPH09500526A (ja) | 1993-06-14 | 1997-01-21 | ベーアーエスエフ アクツィエンゲゼルシャフト | テトラサイクリン反応性プロモーターによる真核細胞の遺伝子発現の厳密な制御 |
| US6914128B1 (en) * | 1999-03-25 | 2005-07-05 | Abbott Gmbh & Co. Kg | Human antibodies that bind human IL-12 and methods for producing |
| UA81743C2 (uk) * | 2000-08-07 | 2008-02-11 | Центокор, Инк. | МОНОКЛОНАЛЬНЕ АНТИТІЛО ЛЮДИНИ, ЩО СПЕЦИФІЧНО ЗВ'ЯЗУЄТЬСЯ З ФАКТОРОМ НЕКРОЗУ ПУХЛИН АЛЬФА (ФНПα), ФАРМАЦЕВТИЧНА КОМПОЗИЦІЯ, ЩО ЙОГО МІСТИТЬ, ТА СПОСІБ ЛІКУВАННЯ РЕВМАТОЇДНОГО АРТРИТУ |
| US6902734B2 (en) * | 2000-08-07 | 2005-06-07 | Centocor, Inc. | Anti-IL-12 antibodies and compositions thereof |
| WO2003031569A2 (en) * | 2001-10-10 | 2003-04-17 | Centocor, Inc. | Nucleic acid vaccines using tumor antigen encoding nucleic acids with cytokine adjuvant encoding nucleic acid |
| US20040156832A1 (en) | 2002-09-30 | 2004-08-12 | Centec Limited | Immunoglobulin compositions and methods |
| MY157915A (en) * | 2004-12-21 | 2016-08-15 | Centocor Inc | Anti-il-12 antibodies, epitopes, compositions, methods and uses. |
| PL1839120T3 (pl) * | 2004-12-21 | 2014-04-30 | Janssen Biotech Inc | Wektory oparte na przeciwciałach anty-IL-12, komórki gospodarza oraz metody wytwarzania i zastosowania |
-
2005
- 2005-12-21 PL PL05855447T patent/PL1839120T3/pl unknown
- 2005-12-21 DK DK05855447.8T patent/DK1839120T3/da active
- 2005-12-21 SI SI200531791T patent/SI1839120T1/sl unknown
- 2005-12-21 PT PT58554478T patent/PT1839120E/pt unknown
- 2005-12-21 ES ES05855447.8T patent/ES2440777T3/es not_active Expired - Lifetime
- 2005-12-21 EP EP05855447.8A patent/EP1839120B1/en not_active Expired - Lifetime
- 2005-12-21 US US11/722,281 patent/US7736650B2/en active Active
- 2005-12-21 WO PCT/US2005/046885 patent/WO2006071804A2/en not_active Ceased
-
2010
- 2010-04-13 US US12/759,154 patent/US8361474B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| WO2006071804A2 (en) | 2006-07-06 |
| US20100216234A1 (en) | 2010-08-26 |
| SI1839120T1 (sl) | 2013-12-31 |
| US20080299133A1 (en) | 2008-12-04 |
| EP1839120A2 (en) | 2007-10-03 |
| WO2006071804A3 (en) | 2007-07-26 |
| ES2440777T3 (es) | 2014-01-30 |
| EP1839120B1 (en) | 2013-10-23 |
| PT1839120E (pt) | 2014-01-03 |
| DK1839120T3 (da) | 2013-11-11 |
| EP1839120A4 (en) | 2008-03-26 |
| US8361474B2 (en) | 2013-01-29 |
| US7736650B2 (en) | 2010-06-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL236427A (en) | Isolated amino acids, vectors, host cells, and antibody preparation methods il-23p19 | |
| IL190472A (en) | Glyphican Antibody 3 Methods for their preparation and use | |
| GB0412973D0 (en) | Identification of antibody producing cells | |
| IL179427A0 (en) | Antibodies as t cell receptor mimics, methods of production and uses thereof | |
| HRP20190220T1 (hr) | Anti-il-23 protutijela, pripravci, postupci i upotrebe | |
| IL183939A0 (en) | Anti - il - 12 antibodies, epitopes, compositions, methods and uses | |
| ZA200804346B (en) | Anit-Aß globulomer antibodies, antigen-binding moieties thereof, corresponding hybridomas, nucleic acids, vectors, host cells, methods of producing said antibodies, compositions comprising said antibodies, uses of said antibodies and methods of using said antibodies | |
| IL211133A0 (en) | Anti-il-6 antibodies, compositions, methods and uses | |
| IL192129A0 (en) | Anti-mn antibodies and methods of using same | |
| PL1974017T5 (pl) | Środki i sposoby do wpływania na stabilność komórek wytwarzających przeciwciała | |
| GB0409482D0 (en) | Fluoropolymer foams,process to make them and applications thereof | |
| EP1937313A4 (en) | HOST CELL LINES USEFUL IN THE PRODUCTION OF A CONSTANT ANTIBODY REGION HAVING IMPROVED FUNCTIONING FUNCTION | |
| IL179236A0 (en) | Griffithsin, glycosylation-resistant griffithsin, and related conjugates, compositions, nucleic acids, vectors, host cells, methods of production and methods of use | |
| EP2214708A4 (en) | VECTORS, HOST CELLS, METHODS OF PRODUCTION AND USES | |
| PT1839120E (pt) | Anticorpo anti-il-12 baseado em vectores, células hospedeiras, e métodos de produção e utilizações | |
| IL177405A0 (en) | Micro fuel cells and methods for the production thereof | |
| IL190014A0 (en) | Antibodies as t cell receptor mimics, methods of production and uses thereof | |
| SI1954718T1 (sl) | Protitelesa proti globulomeru A, njihovi antigen vezavni deli, ustrezni hibridomi, nukleinske kisline, vektorji, gostiteljske celice, postopki za izdelavo teh protiteles, sestavki, ki obsegajo ta protitelesa, uporaba teh protiteles in postopki uporabe teh protiteles | |
| HK1107579A (en) | Anti-il-12 antibodies, epitopes, compositions, methods and uses | |
| GB0419677D0 (en) | Novel polypeptides, antibodies thereto and uses thereof | |
| IL189721A0 (en) | Host cell lines for production of antibody constant region with enhanced effector function | |
| GB0521718D0 (en) | Assays, antibodies and uses thereof | |
| GB0508701D0 (en) | Assays, antibodies and uses thereof |